drugset / Trial / NCT00752297

Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows

NCT00752297 ↗

Phase 3 Completed 402 enrolled Mentor Worldwide, LLC Quintiles, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The overall purpose of this study is to evaluate the safety and effectiveness of an intramuscular dose of Mentor Purified Toxin for the reduction of frown lines, compared with placebo.

Timeline

Start
2007-06
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mentor Purified Toxin Unknown 30 iu Intramuscular

Indications

No indication recorded.